- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03996707
Immediate Weight-bearing Verses Non-Weight-bearing After Foot & Ankle Surgery
Immediate Weight-bearing Verses Non-Weight-bearing After Foot & Ankle Surgery: A Prospective Analysis
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The study is a randomized 1:1, controlled trial, prospective in nature, where participants undergoing foot and ankle surgery will be randomly placed into one of two groups; an immediate weight-bearing group or a non-weight-bearing group. The patients will be randomly placed into the study group and control group if they meet all eligibility criteria.
This study will be conducted at 5 investigative clinic sites; West Penn Hospital, Forbes Regional Hospital, Jefferson Regional Hospital, Bethel Park Surgery Center, and Monroeville Surgery. Recruitment will stop when a minimum of 230 subjects are consented.
The study duration will require 7 visits to the clinic plus a surgery day therefore will require a pre-surgical visit/screening, surgery procedural day and six outpatient post-operative visits to the clinics. The entire follow up period will occur over 2 years.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Pennsylvania
-
Clairton, Pennsylvania, Forente stater, 15025
- Steel Valley Orthopaedic and Sports Medicine
-
Pittsburgh, Pennsylvania, Forente stater, 15224
- The Foot & Ankle Institute/Western Pennsylvania Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Males or females age 18 to 89 years
- Undergoing foot and ankle surgery
- Must be able to read and understand English and consent for themselves
Exclusion Criteria:
- Diagnosed peripheral neuropathy
- Diagnosed peripheral vascular disease
- Documented infection to the surgical extremity
- Previous surgery to the surgical limb
- Laboratory abnormalities that indicate clinically significant hematologic, hepatobiliary, or renal disease which would predispose patients to poor healing and/or non-union
- Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Annen: Immediate protected weight-bearing
|
Immediate protected weight bearing in a CAM walking boot following foot & ankle surgery
Andre navn:
|
|
Annen: Traditional non weight bearing
Strict non-weight-bearing
|
Strict non weight bearing for 6 weeks following foot & ankle surgery
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale
Tidsramme: Both Arms: Screening
|
American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot.
Pain, Function, Alignment Score 0-100, 100 being most healthy
|
Both Arms: Screening
|
|
Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale
Tidsramme: Both Arms: Post-operative 6-8 weeks
|
American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot.
Pain, Function, Alignment Score 0-100, 100 being most healthy
|
Both Arms: Post-operative 6-8 weeks
|
|
Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale
Tidsramme: Both Arms: Post-operative 3 month
|
American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot.
Pain, Function, Alignment Score 0-100, 100 being most healthy
|
Both Arms: Post-operative 3 month
|
|
Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale
Tidsramme: Both Arms: Post-operative 12 month
|
American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot.
Pain, Function, Alignment Score 0-100, 100 being most healthy
|
Both Arms: Post-operative 12 month
|
|
Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale
Tidsramme: Both Arms: Post-operative 24 month
|
American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot.
Pain, Function, Alignment Score 0-100, 100 being most healthy
|
Both Arms: Post-operative 24 month
|
|
Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND
Tidsramme: Both Arms: Screening
|
36 Item Short Form Survey (SF36) RAND.
8 scaled scores, 0-100, 100 being most healthy
|
Both Arms: Screening
|
|
Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND
Tidsramme: Both Arms: Post-operative 6-8 weeks
|
36 Item Short Form Survey (SF36) RAND.
8 scaled scores, 0-100, 100 being most healthy
|
Both Arms: Post-operative 6-8 weeks
|
|
Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND
Tidsramme: Both Arms: Post-operative 3 month
|
36 Item Short Form Survey (SF36) RAND.
8 scaled scores, 0-100, 100 being most healthy
|
Both Arms: Post-operative 3 month
|
|
Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND
Tidsramme: Both Arms: Post-operative 12 month
|
36 Item Short Form Survey (SF36) RAND.
8 scaled scores, 0-100, 100 being most healthy
|
Both Arms: Post-operative 12 month
|
|
Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND
Tidsramme: Both Arms: Post-operative 24 month
|
36 Item Short Form Survey (SF36) RAND.
8 scaled scores, 0-100, 100 being most healthy
|
Both Arms: Post-operative 24 month
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Screening
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Screening
|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Post-operative 2-3 weeks
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Post-operative 2-3 weeks
|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Post-operative 6-8 weeks
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Post-operative 6-8 weeks
|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Post-operative 3 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Post-operative 3 month
|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Post-operative 6 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Post-operative 6 month
|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Post-operative 12 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Post-operative 12 month
|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Post-operative 24 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Post-operative 24 month
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Screening
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Screening
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Post-operative 2-3 weeks
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Post-operative 2-3 weeks
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Post-operative 6-8 weeks
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Post-operative 6-8 weeks
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Post-operative 3 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Post-operative 3 month
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Post-operative 6 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Post-operative 6 month
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Post-operative 12 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Post-operative 12 month
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Tidsramme: Both arms: Post-operative 24 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Post-operative 24 month
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Ryan L. McMillen, DPM, FACFAS, Steel Valley Orthopaedic & Sports Medicine
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- 2019-124JH
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Weight Bearing
-
University of PittsburghFullførtAcetabulær labral tåre | Hip Impingement SyndromeForente stater
-
Hvidovre University HospitalZimmer BiometUkjent
-
University of California, San FranciscoTilbaketrukketSykelig fedmeForente stater
-
Zimmer BiometFullførtArtrose | Traumatisk leddgikt | Avaskulær nekrose av femoralkondylen | Moderat Varus | Valgus | FleksjonsdeformiteterForente stater
-
University of RochesterFullførtOvervekt | OvervektigForente stater
-
University of PennsylvaniaWW International IncFullført
-
University of RochesterFullførtOvervekt | OvervektigForente stater
-
University of North Carolina, Chapel HillWeight Watchers InternationalFullførtOvervekt og fedmeForente stater
-
The Cleveland ClinicAbdominal Core Health Quality CollaborativeFullførtBrokk, Ventral | Insisjonell brokkForente stater